T1	Treatment 10 47	n-3 polyunsaturated fatty acid intake
T2	Treatment 197 250	n-3 polyunsaturated fatty acid (PUFA) supplementation
T3	Treatment 320 409	four 1-g capsules of n-3 PUFA ethyl esters or four 1-g capsules of olive oil (as placebo)
T4	Treatment 606 630	n-3 PUFA supplementation
T5	Treatment 1197 1222	n-3 PUFA supplementation.
